Article
[Delayed effects of cerebrolysin in the prevention of cognitive impairment progression in the first degree relatives of patients with Alzheimer's disease: the role of the ApoE genotype].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2020
Selezneva N D, Gavrilova S I, Kolykhalov I V
Abstract excerpt
OBJECTIVE: To assess the delayed effect of course therapy with cerebrolysin on the cognitive functioning of the first degree relatives of patients with Alzheimer's disease (AD), including, depending on the ApoE4 genotype. MATERIAL AND METHODS: A cohort of 72 blood relatives of patients with AD, including 46 with objectively confirmed clinical and neuropsychological examination signs of mild cognitive dysfunction...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.